to pay the Company’s indebtedness and liabilities. The Company previously held 1,833,150,000 Units. Following the sale of the Units, the Company st ill holds a remaining 1,293,150,000 investment units
accounting and approval of the disposal of investmentsBS Myco Biotech Company Limited ( 2 st review) 28/12/2021 19:33 Notification of the resignation of the Company's director and appointment of a supervisor
% เงนิฝาก/ตราสารหนท้ีเ่ปนการลงทนุในตางประเทศ หรอืมคีวามเสีย่งในตางประเทศ1 - เงินฝาก Agricultural Bank of China - China - Fitch: ST F1 0.8500% 19.00% 0.16% - เงินฝาก Bank of China - China - Fitch: ST
interesting growth direction of business. In the 1 st quarter of 2017, the Company enabled to sell the beverage dispenser (Celli counter beverage dispenser) to a client in CLMV. The Company also organized the
offer in lots as a portion from time to time to investor and the 1 st allotment of 14,500,000 ordinary shares will be allotted to existing shareholder in proportion to 8:1. The Company is granted the
Management Discussion and Analysis for the 2st Quarter 2017 ended August 31 Management Discussion and Analysis for the 2 st Quarter 2017 ended August 31, 2017 AEON Thana Sinsap (Thailand) Public
income Total Reven Discussion and Services Public /017 Manag Presid The St to JMT Net to certify th es for the th mpany’s au rmance of t ted financia 3rd quarter An increase of purchas Company’s iod last
transactions within the past 6 months, is equivalent to 16.65 percent that based on the value of total assets in consolidated financial statement ended December 31 st , 2017. This 16.65 percent transaction size
, and to airtime of the considered a Market Superv isition or Disp Disclosure o ets B.E. 2547 rcent based nsaction size. September 2 eriod prior to ich NNV, a su ces Company assets for st ercent. er the